US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

YD Bio Ltd

19.90

-0.1900-0.95%

Post-market: 19.900.00000.00%17:16 EDT

Volume:72.48K

Turnover:1.49M

Market Cap:1.40B

PE:-15.43

High:22.00

Open:20.39

Low:19.61

Close:20.09

52wk High:31.00

52wk Low:5.30

Shares:70.52M

Float Shares:13.27M

Volume Ratio:1.71

T/O Rate:0.55%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.2901

EPS(LYR):-1.2901

ROE:-42.69%

ROA:-25.43%

PB:212.95

PE(LYR):-15.43

Loading ...

Overview Company News Filings

YD Bio Ltd. Rings Nasdaq Opening Bell to Celebrate Listing under Ticker YDES

YD Bio Says Partner EG Biomed Receives College of American Pathologists Accreditation

MT Newswires Live

BRIEF-YD Bio Limited Reports Unaudited Half Year 2025 Financial Results

YD Bio Limited Reports 9% Decline in Net Revenue to $204,007 for H1 2025

Breeze Holdings Acquisition (YDES) Rises 31% Over the Past Month

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/YDES/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"YDES","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"YDES\",,,,,undefined,":{"symbol":"YDES","market":"US","secType":"STK","nameCN":"YD Bio Ltd","latestPrice":19.9,"timestamp":1760990400000,"preClose":20.09,"halted":0,"volume":72483,"hourTrading":{"tag":"盘后","latestPrice":19.9,"preClose":19.9,"latestTime":"17:16 EDT","volume":43,"amount":855.7,"timestamp":1760994974662},"delay":0,"floatShares":13265400,"shares":70521359,"eps":-1.290101,"marketStatus":"Closed","change":-0.19,"latestTime":"10-20 16:00:00 EDT","open":20.39,"high":22,"low":19.613,"amount":1490023.4711,"amplitude":0.118815,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.290101,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1761033600000},"marketStatusCode":5,"adr":0,"listingDate":1756440000000,"exchange":"NASDAQ","adjPreClose":20.09,"preHourTrading":{"tag":"盘前","latestPrice":20.39,"preClose":20.055,"latestTime":"08:00 EDT","volume":50,"amount":1019.5,"timestamp":1760961603631},"postHourTrading":{"tag":"盘后","latestPrice":19.9,"preClose":19.9,"latestTime":"17:16 EDT","volume":43,"amount":855.7,"timestamp":1760994974662},"volumeRatio":1.708505},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"YDES\",,,,,undefined,":{"symbol":"YDES","floatShares":13265400,"roa":"-25.43%","roe":"-42.69%","lyrEps":-1.290101,"volumeRatio":1.708505,"shares":70521359,"dividePrice":0,"high":22,"amplitude":0.118815,"preClose":20.09,"low":19.613,"week52Low":5.3,"pbRate":"212.95","psRate":"2749.77","week52High":31,"institutionHeld":0,"latestPrice":19.9,"eps":-1.290101,"divideRate":0,"volume":72483,"delay":0,"ttmEps":-1.290101,"open":20.39,"prevYearClose":11.25,"prevWeekClose":20.09,"prevMonthClose":19.47,"prevQuarterClose":19.47,"fiveDayClose":18.46,"twentyDayClose":18.75,"sixtyDayClose":12.05},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/YDES\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-19","symbol":"YDES","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755576000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"YDES\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"YDES\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/YDES\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"YDES","date":"2025-10-17","current":-15.572424,"percent":0.291667,"low":-1151.273969,"twenty":-960.573979,"median":-919.624296,"eighty":-852.27153,"high":-709.645075,"avg":-915.290205,"sd":81.013015,"marketCap":1326583479},"quantilePoints":[{"date":"2025-09-19","current":-961.968859,"twenty":-999.829881,"median":-916.635267,"eighty":-851.374822,"marketCap":1357875801},{"date":"2025-09-26","current":-709.645075,"twenty":-998.136098,"median":-925.353266,"eighty":-851.374822,"marketCap":1001705892},{"date":"2025-10-03","current":-960.225259,"twenty":-973.028263,"median":-916.635267,"eighty":-851.374822,"marketCap":1355414607},{"date":"2025-10-10","current":-932.078579,"twenty":-963.563007,"median":-911.653554,"eighty":-851.474456,"marketCap":1315683907},{"date":"2025-10-17","current":-939.800234,"twenty":-960.573979,"median":-919.624296,"eighty":-852.27153,"marketCap":1326583479}],"updateTime":1760966692780},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"YDES\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2576865071","title":"YD Bio Ltd. Rings Nasdaq Opening Bell to Celebrate Listing under Ticker YDES","url":"https://stock-news.laohu8.com/highlight/detail?id=2576865071","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576865071?lang=en_us&edition=fundamental","pubTime":"2025-10-20 22:20","pubTimestamp":1760970000,"startTime":"0","endTime":"0","summary":"Taipei, Taiwan, Oct.  20, 2025  (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (NasdaqGM: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/20/3169525/0/en/YD-Bio-Ltd-Rings-Nasdaq-Opening-Bell-to-Celebrate-Listing-under-Ticker-YDES.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NQmain","TQQQ","PSQ","YDES","NVIW.SI","USAW.SI","QLD","SQQQ","MNQmain","08212",".IXIC","USJW.SI","QID","TSYW.SI"],"gpt_icon":1},{"id":"2574171339","title":"YD Bio Says Partner EG Biomed Receives College of American Pathologists Accreditation","url":"https://stock-news.laohu8.com/highlight/detail?id=2574171339","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574171339?lang=en_us&edition=fundamental","pubTime":"2025-10-10 21:14","pubTimestamp":1760102063,"startTime":"0","endTime":"0","summary":"YD Bio  said Friday that its business partner EG Biomed US has received College of American Pathologists accreditation for its CLIA-certified laboratory in Bothell, Washington.The accreditation is considered the gold standard in laboratory quality assurance and confirms that EG Biomed meets the standards of excellence in lab operations, the company said.EG Biomed is one of YD Bio's licensing partners for pancreatic and breast cancer detection and with 3D Global to develop eye disorder therapies, according to the biotechnology company.Shares of YD Bio were up more than 12% in recent Friday premarket activity.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4107","AFG","IE00B19Z3581.USD","LU0077335932.USD","LU0211331839.USD","EG","BK4117","YDES","IE00B19Z3B42.SGD","BK4588","BK4019","IE0002270589.USD","BK4585"],"gpt_icon":0},{"id":"2572370459","title":"BRIEF-YD Bio Limited Reports Unaudited Half Year 2025 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2572370459","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572370459?lang=en_us&edition=fundamental","pubTime":"2025-10-01 06:33","pubTimestamp":1759271583,"startTime":"0","endTime":"0","summary":"BRIEF-YD Bio Limited Reports Unaudited Half Year 2025 Financial ResultsSept 30 (Reuters) - YD Bio Ltd YDES.O:YD BIO LIMITED REPORTS UNAUDITED HALF YEAR 2025 FINANCIAL RESULTSSource text: ID:nGNX9vZJNmFurther company coverage: YDES.O ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nTUA7WHXJ8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YDES"],"gpt_icon":0},{"id":"2572372740","title":"YD Bio Limited Reports 9% Decline in Net Revenue to $204,007 for H1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2572372740","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572372740?lang=en_us&edition=fundamental","pubTime":"2025-10-01 05:25","pubTimestamp":1759267518,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. YD Bio Limited published the original content used to generate this news brief via GlobeNewswire  on September 30, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nNDL1s38m5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BK4023","BK4588","IE00B64PRP62.GBP","LU2095319765.USD","IE00BGHQF748.EUR","NDAQ","LU1815336091.USD","BK4585","IE00BKPKM429.USD","LU0314104364.USD","LU2210149790.SGD","LU0757428866.USD","BL","YDES","IE00B3QW5Z07.USD","BK4112"],"gpt_icon":0},{"id":"2566803729","title":"Breeze Holdings Acquisition (YDES) Rises 31% Over the Past Month","url":"https://stock-news.laohu8.com/highlight/detail?id=2566803729","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2566803729?lang=en_us&edition=fundamental","pubTime":"2025-09-11 04:18","pubTimestamp":1757535539,"startTime":"0","endTime":"0","summary":"In recent events, YD Bio Limited's addition to the NASDAQ Composite Index has elevated the company's market standing, while Breeze Holdings Acquisition (YDES) has seen a 31% price rise over the past month. This surge coincides with significant developments, including a business combination with Taiwan-based YD Biopharma, signaling a move to strengthen their presence in the biopharmaceutical industry. These corporate actions place the company's recent performance against the backdrop of a...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ydes/breeze-holdings-acquisition/news/breeze-holdings-acquisition-ydes-rises-31-over-the-past-mont","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ydes/breeze-holdings-acquisition/news/breeze-holdings-acquisition-ydes-rises-31-over-the-past-mont","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["YDES","BREZU"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}]}}